Pancreatic Cancer Research

ResearcherChiba UniversityNo recent work listed

Katsunori Furukawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3280-683X; OpenAlex author ID A5057737030, A5080766585. Sources: ClinicalTrials.gov.

Their work

Papers
27
Trials
2
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2009: 1 trial · 2010: none · 2011: none · 2012: 1 paper · 2013: 1 trial · 2014: 2 papers · 2015: 2 papers · 2016: 3 papers · 2017: 6 papers · 2018: 2 papers · 2019: 3 papers · 2020: 2 papers · 2021: 4 papers · 2022: 2 papers

Papers 27

  1. The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s10585-021-10142-7↗
  2. Prosaposin, tumor-secreted protein, promotes pancreatic cancer progression by decreasing tumor-infiltrating lymphocytes. Co-author DOI 10.1111/cas.15444↗
  3. Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. Co-author DOI 10.1007/s13402-021-00614-z↗
  4. Simultaneous brain and lung metastases of pancreatic ductal adenocarcinoma after curative pancreatectomy: a case report and literature review. Co-author DOI 10.1186/s12876-020-01587-3↗
  5. C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pan… Co-author DOI 10.1186/s13046-021-02019-0↗
  6. Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2020.12388↗
  7. Comparing prognostic factors of Glut-1 expression and maximum standardized uptake value by FDG-PET in patients with resectable pancreatic cancer. Co-author DOI 10.1016/j.pan.2020.07.407↗
  8. Needle tract seeding recurrence of pancreatic cancer in the gastric wall with paragastric lymph node metastasis after endoscopic ultrasound-guided fine needle … Co-author DOI 10.1186/s12876-020-1159-x↗
  9. Conversion surgery for initially unresectable pancreatic cancer: current status and unresolved issues. Co-author DOI 10.1007/s00595-019-01804-x↗
  10. Is hepatic artery coil embolization useful in distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic cancer? Co-author DOI 10.1186/s12957-019-1667-8↗
  11. Successful treatment of a locally advanced unresectable pancreatic cancer patient with interstitial pneumonitis by conversion surgery following gemcitabine plu… Co-author DOI 10.3892/mco.2019.1807↗
  12. Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer. Co-author DOI 10.3892/ijmm.2018.3652↗
  13. Conversion surgery with gemcitabine plus nab-paclitaxel for locally advanced unresectable pancreatic cancer: A case report. Co-author DOI 10.3892/mco.2018.1688↗
  14. Grainyhead-like 2 (GRHL2) regulates epithelial plasticity in pancreatic cancer progression. Co-author DOI 10.1002/cam4.1212↗
  15. Combined hepatic arterial resection in pancreatic resections for locally advanced pancreatic cancer. Co-author DOI 10.1007/s00423-017-1578-5↗
  16. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal ad… Co-author DOI 10.1016/j.cyto.2017.02.007↗
  17. Sex Determining Region Y Box 9 Induces Chemoresistance in Pancreatic Cancer Cells by Induction of Putative Cancer Stem Cell Characteristics and Its High Expres… Co-author DOI 10.1097/mpa.0000000000000945↗
  18. Metadherin promotes metastasis by supporting putative cancer stem cell properties and epithelial plasticity in pancreatic cancer. Co-author DOI 10.18632/oncotarget.19802↗
  19. [IV. Distal Pancreatectomy with Celiac Axis Resection(DP-CAR)for Locally Advanced Pancreatic Cancer with Celiac Artery Invasion]. Co-author PMID 29066679↗
  20. Low Stromal Area and High Stromal Microvessel Density Predict Poor Prognosis in Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000499↗
  21. [Two Cases of Remnant Pancreatic Cancer Treated Using Remnant Pancreatectomy Combined with Hepatic Arterial Resection]. Co-author PMID 28133092↗
  22. [A Case of Early-Onset Rapidly Progressive Cerebral Infarction with Trousseau's Syndrome in a Patient with Pancreatic Cancer Undergoing Surgery]. Co-author PMID 28133197↗
  23. [III. Repeat pancreatectomy for recurrent pancreatic cancer]. Co-author PMID 26665417↗
  24. [A Case of R0 Resection of Locally Advanced Pancreatic Cancer Following Chemoradiation Therapy]. Co-author PMID 26805371↗
  25. Tips and tricks of surgical technique for pancreatic cancer: portal vein resection and reconstruction (with videos). Co-author DOI 10.1002/jhbp.128↗
  26. [Liver, pancreas, biliary tract cancer. III. Pancreatectomy with Vascular Resection for Locally Advanced Pancreatic Cancer]. Co-author PMID 25528776↗
  27. Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells. Co-author DOI 10.1016/j.jss.2012.05.065↗

Trials 2

  1. Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy Study director NCT01969110↗
  2. Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy Study director NCT01256034↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shigetsugu Takano · 26 shared papers, 2012–2022 · strength 2.14
  2. Masayuki Ohtsuka · 25 shared papers, 2012–2022 · strength 2.11
  3. Hideyuki Yoshitomi · 22 shared papers, 2012–2021 · strength 1.49
  4. Shingo Kagawa · 19 shared papers, 2012–2021 · strength 1.24
  5. Masaru Miyazaki · 18 shared papers, 2012–2021 · strength 1.09
  6. Yoji Miyahara · 5 shared papers, 2015–2022 · strength 0.57
  7. Kazuyuki Sogawa · 3 shared papers, 2021–2022 · strength 0.40
  8. Kosuke Sasaki · 3 shared papers, 2021 · strength 0.37
  9. Satoshi Tomizawa · 2 shared papers, 2021–2022 · strength 0.30
  10. Tetsuo Yokota · 3 shared papers, 2018–2020 · strength 0.26
  11. Fumio Nomura · 3 shared papers, 2012–2021 · strength 0.26
  12. Reiri Shimazaki · 3 shared papers, 2017–2021 · strength 0.25
  13. Atsuhiko Ueda · 3 shared papers, 2016–2019 · strength 0.20
  14. Kenji Kawahara · 1 shared paper, 2022 · strength 0.19
  15. Hitoe Nishino · 2 shared papers, 2017 · strength 0.14
  16. Kensuke Suzuki · 2 shared papers, 2017 · strength 0.14
  17. Mamoru Satoh · 2 shared papers, 2012–2021 · strength 0.14
  18. Yoshito Oka · 1 shared paper, 2021 · strength 0.11
  19. Yusuke Kouchi · 1 shared paper, 2021 · strength 0.11
  20. Takanori Konishi · 1 shared paper, 2021 · strength 0.11
  21. Takashi Kishimoto · 1 shared paper, 2021 · strength 0.11
  22. Makoto Takahashi · 1 shared paper, 2020 · strength 0.11
  23. Takahiro Nishida · 2 shared papers, 2015–2016 · strength 0.10
  24. Nami Sato · 1 shared paper, 2020 · strength 0.10
  25. Naoya Kato · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.